NYSEARCA:LABD Direxion Daily S&P Biotech Bear 3x Shares (LABD) Price, Holdings, & News $12.20 +1.85 (+17.87%) Closing price 04/4/2025 04:10 PM EasternExtended Trading$12.26 +0.07 (+0.53%) As of 04/4/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipBuy This Stock About Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LABD alerts:Sign Up Key Stats Today's Range$10.78▼$12.3350-Day Range$6.15▼$12.2052-Week Range$4.78▼$12.33Volume13.60 million shsAverage Volume16.81 million shsMarket Capitalization$68.56 millionAssets Under Management$48.23 millionDividend Yield2.79%Net Expense Ratio1.10%Aggregate RatingN/A ETF OverviewThe Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.Read More… Remove Ads Direxion Daily S&P Biotech Bear 3x Shares ExpensesTypeLABDHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.57%0.56%0.51%0.53%Other Expenses0.37%0.30%0.50%0.57%0.53%Total Expense1.12%0.70%0.73%0.73%0.72%Fee Waiver-0.02%-0.45%-0.50%-0.66%-0.56%Net Expense1.10%0.61%0.63%0.58%0.60% Receive LABD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Email Address LABD ETF News HeadlinesDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.1264December 24, 2024 | msn.comDirexion Daily S&P Biotech Bear 3X Shares (LABD) Dividend HistoryDecember 23, 2024 | nasdaq.comTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…April 5, 2025 | Paradigm Press (Ad)Direxion Daily S&P 500 Bear 3X (ARCA:SPXS), Short Interest ReportOctober 15, 2024 | benzinga.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0890September 24, 2024 | msn.comDirexion Daily S&P Biotech Bear 3X ETF (LABD)August 24, 2024 | uk.finance.yahoo.comSee More Headlines LABD ETF - Frequently Asked Questions How have LABD shares performed this year? Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $7.25 on January 1st, 2025. Since then, LABD stock has increased by 68.3% and is now trading at $12.20. View the best growth stocks for 2025 here. When did Direxion Daily S&P Biotech Bear 3x Shares' stock split? Shares of Direxion Daily S&P Biotech Bear 3x Shares reverse split on Friday, August 28th 2020. The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of Direxion Daily S&P Biotech Bear 3x Shares? Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bear 3x Shares investors own include Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Micron Technology (MU), Direxion Daily S&P Biotech Bull 3x Shares (LABU), NVIDIA (NVDA) and Intel (INTC). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bear 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABD Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings17 Fund Statistics Assets Under Management$48.23 million Average Daily Volume$10.37 million Discount/Premium0.04% Leveraged-3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume3,207 Put Options444 Call Options2,763 Short Interest2,060,000 shs Miscellaneous Outstanding Shares5,620,000Beta-2.43 Creation Unit50,000 Creation Fee$250.00 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report Top 10 LABD HoldingsDREYFUS GOVT CASH MAN INSHolding Weight: 36.70%GOLDMAN FINL SQ TRSRY INST 506Holding Weight: 35.38%DREYFUS TRSRY SECURITIES CASH MGMTHolding Weight: 15.39%GOLDMAN SACHS FIN GOV 465 INSTITUTHolding Weight: 13.82%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: -6.05%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: -26.51%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: -36.40%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: -61.94%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: -76.83%S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPHolding Weight: -92.26%Full Holdings Details This page (NYSEARCA:LABD) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bear 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bear 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.